Search research articles
Contact Us
Filters
Showing results (91-100 of 158) with videos related to
Page
of 16
Sort By:
American Journal of Physiology. Renal Physiology
|
December 18, 2009
Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy
Adeline L Y Tan, Karly C Sourris, Brooke E Harcourt, et al.
Islets
|
November 22, 2017
Perinatal exposure to high dietary advanced glycation end products in transgenic NOD8.3 mice leads to pancreatic beta cell dysfunction
Danielle J Borg, Felicia Y T Yap, Sahar Keshvari, et al.
American Journal of Nephrology
|
August 31, 2011
Advanced glycation urinary protein-bound biomarkers and severity of diabetic nephropathy in man
Melinda T Coughlan, Sheila K Patel, George Jerums, et al.
Frontiers in Physiology
|
September 20, 2021
Characterisation of the Myocardial Mitochondria Structural and Functional Phenotype in a Murine Model of Diabetic Cardiomyopathy
Alex M Parker, Mitchel Tate, Darnel Prakoso, et al.
Journal of Hypertension
|
February 27, 2010
Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase
Aino Soro-Paavonen, Wei-Zeng Zhang, Kylie Venardos, et al.
Journal of Neurology
|
October 16, 2012
Longitudinal assessment of thrombin generation potential in response to alteration of antiplatelet therapy after TIA or ischaemic stroke
W O Tobin, J A Kinsella, G F Kavanagh, et al.
Journal of the Neurological Sciences
|
August 28, 2022
Assessment of on-treatment platelet reactivity at high and low shear stress and platelet activation status after the addition of dipyridamole to aspirin in the early and late phases after TIA and ischaemic stroke
S T Lim, S J X Murphy, S M Murphy, et al.
Journal of Neurology
|
May 1, 2014
Longitudinal assessment of von Willebrand factor antigen and von Willebrand factor propeptide in response to alteration of antiplatelet therapy after TIA or ischaemic stroke
W O Tobin, J A Kinsella, G F Kavanagh, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 7, 2020
Intravascular Follistatin gene delivery improves glycemic control in a mouse model of type 2 diabetes
Jonathan R Davey, Emma Estevez, Rachel E Thomson, et al.
Redox Biology
|
October 1, 2021
SOD2 in skeletal muscle: New insights from an inducible deletion model
Aowen Zhuang, Christine Yang, Yingying Liu, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 158) with videos related to
Sort By:
Page
of 16
American Journal of Physiology. Renal Physiology
|
December 18, 2009
Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy
Adeline L Y Tan, Karly C Sourris, Brooke E Harcourt, et al.
Islets
|
November 22, 2017
Perinatal exposure to high dietary advanced glycation end products in transgenic NOD8.3 mice leads to pancreatic beta cell dysfunction
Danielle J Borg, Felicia Y T Yap, Sahar Keshvari, et al.
American Journal of Nephrology
|
August 31, 2011
Advanced glycation urinary protein-bound biomarkers and severity of diabetic nephropathy in man
Melinda T Coughlan, Sheila K Patel, George Jerums, et al.
Frontiers in Physiology
|
September 20, 2021
Characterisation of the Myocardial Mitochondria Structural and Functional Phenotype in a Murine Model of Diabetic Cardiomyopathy
Alex M Parker, Mitchel Tate, Darnel Prakoso, et al.
Journal of Hypertension
|
February 27, 2010
Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase
Aino Soro-Paavonen, Wei-Zeng Zhang, Kylie Venardos, et al.
Journal of Neurology
|
October 16, 2012
Longitudinal assessment of thrombin generation potential in response to alteration of antiplatelet therapy after TIA or ischaemic stroke
W O Tobin, J A Kinsella, G F Kavanagh, et al.
Journal of the Neurological Sciences
|
August 28, 2022
Assessment of on-treatment platelet reactivity at high and low shear stress and platelet activation status after the addition of dipyridamole to aspirin in the early and late phases after TIA and ischaemic stroke
S T Lim, S J X Murphy, S M Murphy, et al.
Journal of Neurology
|
May 1, 2014
Longitudinal assessment of von Willebrand factor antigen and von Willebrand factor propeptide in response to alteration of antiplatelet therapy after TIA or ischaemic stroke
W O Tobin, J A Kinsella, G F Kavanagh, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 7, 2020
Intravascular Follistatin gene delivery improves glycemic control in a mouse model of type 2 diabetes
Jonathan R Davey, Emma Estevez, Rachel E Thomson, et al.
Redox Biology
|
October 1, 2021
SOD2 in skeletal muscle: New insights from an inducible deletion model
Aowen Zhuang, Christine Yang, Yingying Liu, et al.
Page
of 16